FOX vs PMCB · P/E 13, rev $16.30B vs $8.6M cap
Fox Corp Class B (FOX) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the FOX and PMCB stock pages for the full models.
Not investment advice.